Canada's Valeant again ups bid for Botox maker
Canadian pharmaceutical firm Valeant on Friday upped for the second time in a week its hostile bid for Allergan, the US maker of Botox, to $53.5 billion.
May 31, 2014
Archive: 31/05/2014
New genetic sequencing methods mean quicker, cheaper, and accurate embryo screening
Results from the first study of the clinical application of next generation DNA sequencing (NGS) in screening embryos for genetic disease prior to implantation in patients undergoing in-vitro fertilisation treatments show ...
May 31, 2014
Researchers take a major step towards better diagnosis and treatment of osteoporosis
A new target that may be critical for the treatment of osteoporosis, a disease which affects about 25% of post-menopausal women, has been discovered by a group of researchers in The Netherlands and in Germany. Professor Brunhilde ...
May 31, 2014
